{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/headache-medication-overuse/management/management/","result":{"pageContext":{"chapter":{"id":"5aa2d427-7d2b-5110-b3c3-149b3c9ae20f","slug":"management","fullItemName":"Scenario: Management","depth":2,"htmlHeader":"<!-- begin field dfd3581a-6faf-441c-ace6-0a1bebea648d --><h2>Scenario: Management of medication overuse headache</h2><!-- end field dfd3581a-6faf-441c-ace6-0a1bebea648d -->","summary":"Covers the management of people with medication overuse headache.","htmlStringContent":"<!-- begin item 6f9e4479-b03a-454a-a5c4-5ee22a990460 --><!-- begin field f5888b48-f573-4010-a429-acbc015778e4 --><p>From age 16 years onwards.</p><!-- end field f5888b48-f573-4010-a429-acbc015778e4 --><!-- end item 6f9e4479-b03a-454a-a5c4-5ee22a990460 -->","topic":{"id":"c3e2af9a-7e39-5197-9eb3-1ed7a0e55408","topicId":"876b21f6-c785-4745-8233-2a56adca5e2f","topicName":"Headache - medication overuse","slug":"headache-medication-overuse","lastRevised":"Last revised in November 2017","chapters":[{"id":"40857afc-808e-588e-8df4-4d8b15ec657a","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"63871d8d-20ed-5111-b909-c671b7d8290d","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"9cae9867-86cc-59c4-b6bf-f373dcba4164","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"8249aff5-50e4-5d82-9408-80a413334b35","slug":"changes","fullItemName":"Changes"},{"id":"db547c32-5bee-554a-a0b2-dc3586cf0545","slug":"update","fullItemName":"Update"}]},{"id":"2abe896d-4027-5ea6-b53c-4126bd2728c4","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"38f0d3b1-709d-5342-b729-a1341e432308","slug":"goals","fullItemName":"Goals"},{"id":"a38c1ab1-09de-5ef7-baff-841d15605039","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"43907ef2-b709-5ebe-b83b-ab23bc9ed6ca","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"0feb34c0-feb0-5b65-a4c1-32baeee2a780","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"dd0c4d51-1d5a-5ed5-913d-c4891dbdcdad","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"5b6a60a6-ec80-5422-af6f-b6397fc4eb49","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"3cd81fd7-0d7a-552d-84fc-71226d45fd89","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"3d866153-0662-5ce8-b955-3970472be336","slug":"definition","fullItemName":"Definition"},{"id":"d33eb885-20a8-5803-a999-aceb7adffb72","slug":"causes","fullItemName":"Causes"},{"id":"f8475e5f-a2f9-5002-932a-d7ba4870aa9f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"a1c40b6b-4520-56e8-b2fa-bb765751e34f","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"b50624f5-1fc7-5aae-8abf-9c5d20c25996","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"c264e53b-3cbc-5157-819e-b2829d10ddf3","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"7a8b4459-1ea1-567d-894f-eee914a8f3e0","slug":"assessment","fullItemName":"Assessment"},{"id":"0fffe194-2a62-5cc8-921c-70edbfaaee2f","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"24bded00-bd1c-5e35-8d9e-e9cbdb170491","fullItemName":"Management","slug":"management","subChapters":[{"id":"5aa2d427-7d2b-5110-b3c3-149b3c9ae20f","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"2d1b86f8-d377-5c3d-9334-138f4cdb5622","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"e8ea0b38-7c95-5427-8107-b6506325dd95","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"83630e7e-e220-5043-af84-8cf6a05f13d4","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"9d829e6b-790e-5c8c-b792-58adea1a2dd3","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"7de26ebd-eda1-5880-8547-e657d94fc6a0","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"e74b3fd8-6eac-5d2e-886c-97583955d536","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"3ce1ab25-89c2-5795-9e6a-493771574210","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"78c55256-334c-5f3e-8d0f-80013fc16bc9","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"24bded00-bd1c-5e35-8d9e-e9cbdb170491","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"1d7fd600-b829-5531-8046-96a3cc90c595","slug":"management-of-moh","fullItemName":"Management of MOH","depth":3,"htmlHeader":"<!-- begin field 5d181bf5-5913-441c-93ed-b521b1f5cb6c --><h3>How should I manage medication overuse headache?</h3><!-- end field 5d181bf5-5913-441c-93ed-b521b1f5cb6c -->","summary":null,"htmlStringContent":"<!-- begin item 39cae11d-73eb-4da6-ae7e-8772e89844d2 --><!-- begin field 056b3765-2e44-4b50-9f16-025d1590983c --><ul><li><strong>If the person has any red flags for a serious <a class=\"topic-reference internal-reference\" href=\"/topics/headache-medication-overuse/diagnosis/differential-diagnosis/\">secondary cause of headache</a>:</strong><ul><li>Refer to secondary care (with urgency depending on the clinical situation).</li><li>For information on red flags see the section on <a class=\"topic-reference external-reference\" href=\"/topics/headache-assessment/diagnosis/headache-diagnosis/#red-flags\">warning features of serious causes of headache</a> in the CKS topic <a class=\"topic-reference external-reference\" href=\"/topics/headache-assessment/\">Headache - assessment</a>.</li></ul></li><li><strong>If <a class=\"topic-reference internal-reference\" href=\"/topics/headache-medication-overuse/diagnosis/clinical-features/\">clinical features</a> are consistent with medication overuse headache (MOH):</strong><ul><li>Explain the diagnosis of MOH and that withdrawal of the overused drug is the mainstay of treatment.</li><li>Discuss with/refer to neurology if overuse involves opioids or tranquillizers, significant comorbidities are present or previous repeated withdrawal attempts have been unsuccessful in primary care – inpatient withdrawal may be required.</li><li>Support withdrawal of the offending medication if appropriate to do so in primary care.<ul><li>Drugs such as triptans and simple analgesics (such as NSAIDS and paracetamol) can generally be stopped abruptly.</li><li>Advise the person to stop taking all overused acute headache medications for at least 1 month.</li><li>Warn the person that withdrawal may initially worsen symptoms and that headache improvement may not occur for weeks after discontinuation.</li><li>Advise the person to keep a diary recording symptoms and medication use during withdrawal and to maintain good hydration.</li></ul></li><li>Ensure associated comorbidities such as anxiety and depression are appropriately managed.<ul><li>For more information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/depression/\">Depression</a> and <a class=\"topic-reference external-reference\" href=\"/topics/generalized-anxiety-disorder/\">Generalized anxiety disorder</a>.</li></ul></li><li>Provide written and oral information on MOH, pre-existing primary headache disorder(s) and prevention of relapse.<ul><li>Education on recognition of specific headache types allows the person to use medication more appropriately. For further information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/headache-tension-type/\">Headache - tension-type</a> and <a class=\"topic-reference external-reference\" href=\"/topics/migraine/\">Migraine</a>.</li></ul></li><li>Arrange follow up to monitor progress and support the person.<ul><li>Review and reassess the underlying primary headache disorder 4–8 weeks after withdrawing the overused medication.</li><li>Original headache type (migraine or tension-type headache) is usually revealed within 2 months of withdrawal. If appropriate, the overused medications may be reintroduced after 2 months, with clear restrictions on frequency of use.</li><li>If relapse occurs, provide ongoing support — behavioural interventions (such as cognitive behaviour therapy and stress reduction) may help.</li><li>For further information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/headache-assessment/\">Headache - assessment</a>, <a class=\"topic-reference external-reference\" href=\"/topics/headache-tension-type/\">Headache - tension-type</a> and <a class=\"topic-reference external-reference\" href=\"/topics/migraine/\">Migraine</a>.</li></ul></li></ul></li><li>If uncertain about diagnosis/management or first line measures in primary care fail discuss with a neurologist or GP with a special interest in headache.</li></ul><!-- end field 056b3765-2e44-4b50-9f16-025d1590983c --><!-- end item 39cae11d-73eb-4da6-ae7e-8772e89844d2 -->","subChapters":[{"id":"c2d6246a-635a-564e-8fb9-5ad3835c8713","slug":"basis-for-recommendation-78c","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 09be961c-5052-42ed-9647-924a74e6cbd6 --><h4>Basis for recommendation</h4><!-- end field 09be961c-5052-42ed-9647-924a74e6cbd6 -->","summary":null,"htmlStringContent":"<!-- begin item 78c8e10e-bccd-45d6-814f-76e9587d5ee8 --><!-- begin field 1ca4c23b-cdcc-4b2b-898c-10df282da2fc --><p>The recommendations on the management of medication overuse headache (MOH) are based on the clinical guidelines <em>Guidelines for all healthcare professionals in the diagnosis and management of migraine, tension-type, cluster and medication-overuse headache</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">BASH, 2010</a>], <em>Headaches in over 12s: diagnosis and management (updated November 2015)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">NICE, 2012</a>], <em>The International Classification of Headache Disorders, 3rd edition (beta version)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">IHS, 2013</a>], and <em>Guideline for primary care management of headache in adults</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Becker, 2015</a>]  and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Katsarava, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Saper, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Da Silva, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Kristoffersen, 2014b</a>] and [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Kristoffersen, 2014a</a>].</p><h5>Explain the diagnosis</h5><ul><li>Expert opinion in clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">NICE, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">IHS, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Becker, 2015</a>] and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Katsarava, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Saper, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Kristoffersen, 2014b</a>] is that patient education is essential in management of MOH.<ul><li>A Norwegian prospective cohort study (n=109) found that provision of basic information on appropriate medication use led to a reduction in mean medication days from 22 days to 6 days per month. At follow up (18 months) 76% of participants no longer had MOH [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Grande, 2011</a>].</li></ul></li></ul><h5>Drug withdrawal</h5><ul><li>Guidelines from the National Institute for Health and Care Excellence (NICE) and British Association for the Study of Headache (BASH) recommend that specialist referral and/or inpatient withdrawal of overused medication should be considered for people using strong opioids, with relevant comorbidities, or in whom previous repeated withdrawal attempts have been unsuccessful [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">BASH, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">NICE, 2012</a>].</li><li>Withdrawal of the suspected medication(s) is the only treatment for established MOH [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">BASH, 2010</a>].<ul><li>Ergots, triptans, and simple non-opioid analgesia can be stopped abruptly.</li></ul></li><li>Withdrawal symptoms may occur and time to recovery is variable [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">BASH, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">NICE, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Becker, 2015</a>]:<ul><li>Abrupt withdrawal may precipitate withdrawal headache which usually lasts 2–10 days (average 3.5 days) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">BASH, 2010</a>].</li><li>Other withdrawal symptoms may include nausea, vomiting, hypotension, tachycardia, sleep disturbances, restlessness, anxiety and nervousness [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">BASH, 2010</a>].</li><li>Time taken to improvement varies depending on the drug overused — triptans or ergots generally take 7-10 days and simple analgesics 2-3 weeks [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">BASH, 2010</a>].</li></ul></li></ul><h5>Management of co-morbidities</h5><ul><li>Expert opinion in clinical guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Becker, 2015</a>] and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Johnson, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Saper, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Da Silva, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Kristoffersen, 2014b</a>] is that MOH is influenced by psychiatric co-morbidities such as anxiety and depression and for treatment to be successful these must be appropriately managed.</li></ul><h5>Follow up and support</h5><ul><li>Expert opinion in clinical guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">NICE, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Becker, 2015</a>] recommends patient follow-up and support.</li><li>Headache diaries recording symptoms and intake of acute and symptomatic medications are important in recognition of co-existing primary headaches and prevention and treatment of medication-overuse headache [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Becker, 2015</a>].</li></ul><h5>Referral</h5><ul><li>Diagnosis of MOH is presumptive — withdrawal of overused medication on some occasions may not lead to recovery. If chronic headache persists, assessment for an alternative diagnosis and specialist referral is indicated [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">BASH, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Kristoffersen, 2014b</a>].</li></ul><!-- end field 1ca4c23b-cdcc-4b2b-898c-10df282da2fc --><!-- end item 78c8e10e-bccd-45d6-814f-76e9587d5ee8 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}